Source link : https://newshealth.biz/health-news/decnupaz-approved-for-rare-blood-cancer/
The FDA approved the antibody-drug conjugate pivekimab sunirine (Decnupaz) for the rare hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN). The approval stipulates use of the drug in adults. Although BPDCN occurs most often in patients ages 60 and older, the condition can affect patients in any age group. Primary support for the approval came […]
The post Decnupaz Approved for Rare Blood Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-27 21:25:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8